91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
In this piece from Forbes, Dr. Greg Licholai, Chief Medical and Chief Innovation Officer talks about how, .
-
This article by Carrye Nibblelink, Executive Director, Decentralised Clinical Trial Solutions in the Journal of mHealth explores how the throughout their clinical trial journey.
Copyright 2023 The Journal of mHealth (Simidics Ltd)
-
This article explores the benefits and challenges of .
Clinical Trials Arena
-
In this interview on Newstalk Breakfast Business,
-
This article from the Business Post covers 91黑料’s Q2 2023 financial results, reporting that the on the back of increased contract wins.
-
This article from RTE reports on and features an interview with Steve Cutler, CEO, 91黑料.
? RT? 2023
-
91黑料’s Chief Medical and Innovation Officer, Greg Licholai, explores this topic in his recent column in Forbes.
-
Diarmaid Cunningham, Chief Administrative Officer, discusses in Drug Discovery World.
Copyright 2023 ? Drug Discovery World (DDW)
-
A key feature of the EU CTR is the introduction of a single electronic portal, , which is mandatory for all EU CTR submissions. over the lifecycle of clinical trials across the EU/EEA.
Published by Journal Volume 6 Issue 2
-
If there is a variety of treatment options in a specific disease area, decision makers require evidence of efficacy and safety of novel interventions in comparison to established treatments. One is not sufficient to come to a final conclusion, especially since RCTs often present contradictory results.
Published by Journal for Clinical Studies Volume 15 Issue 2 ().
